Skip to main content
NIH funding notice PAR-24-044

NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)

Closed on November 17, 2025.

Posted
November 27, 2023
Close date
November 17, 2025
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $524,243 in first-year total cost, median $524,243.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 NV-C (10)]1

Most frequent institutions

  1. INTRINSIC POWERS, INC.1
Competing awards under PAR-24-044 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Portable TMS-EEG device for bedside detection of covert consciousness1R41NS137850-01A1BOLY, MELANIEINTRINSIC POWERS, INC., WI$524,243ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-24-044: NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required) | ScienceDex | ConductScience